58 filings
Page 2 of 3
8-K
xwrr4
1 Nov 22
Axcella Reports Third Quarter Financial Results and Provides Business Update
8:02am
8-K
cu28l 1rly
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
xx4i0kouiwzrp9zpy
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
xvi atni2ys0
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
ifmfvra6 p336
12 Aug 22
Axcella Reports Second Quarter Financial Results and Provides Business Update
8:11am
8-K
dyg4g
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
b79vwt3jw2mg23
26 May 22
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
8:12am
8-K
kdlax836
25 May 22
Departure of Directors or Certain Officers
5:01pm
8-K
wecw 7kyx4yicsdtx
5 May 22
Axcella Reports First Quarter Financial Results and Provides Business Update
7:41am
8-K
bro00bs4 65w67s9nw
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
8-K
ggawl6ex29ae
18 Mar 22
Termination of a Material Definitive Agreement
4:05pm
8-K
16n0hy4f 8vbq
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
f9k0y
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
gp98 xdii
10 Jan 22
Other Events
8:00am
8-K
cd2cgo
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
5ficoivq8jssx
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
tymqt 076vbeluw4j
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
ing f3obvgd8sv9r1dg
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
2a3u dp47e
21 May 21
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
vjhoynt 4az
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am